Biochemical Reconstitution of Steroid Receptor•Hsp90 Protein Complexes and Reactivation of Ligand Binding

被引:0
|
作者
Murphy, Patrick J. M. [1 ]
Franklin, Hannah R. [2 ]
Furukawa, Nathan W. [3 ]
机构
[1] Seattle Univ, Interdisciplinary Life Sci Res Lab, Coll Nursing, Seattle, WA 98122 USA
[2] Seattle Univ, Coll Sci & Engn, Interdisciplinary Life Sci Res Lab, Seattle, WA USA
[3] Univ Washington, Sch Med, Seattle, WA 98195 USA
来源
基金
美国国家卫生研究院;
关键词
Biochemistry; Issue; 55; glucocorticoid receptor; hsp90; molecular chaperone protein; in vitro reconstitution; steroid binding; biochemistry; immunoadsorption; immunoprecipitation; Experion; western blot; GLUCOCORTICOID-RECEPTOR; CHAPERONE MACHINERY; HSP90; TRAFFICKING; HSP70; ATP;
D O I
10.3791/3059
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hsp90 is an essential and highly abundant molecular chaperone protein that has been found to regulate more than 150 eukaryotic signaling proteins, including transcription factors (e.g. nuclear receptors, p53) and protein kinases (e.g. Src, Raf, Akt kinase) involved in cell cycling, tumorigenesis, apoptosis, and multiple eukaryotic signaling pathways(1),(2). Of these many 'client' proteins for hsp90, the assembly of steroid receptor center dot hsp90 complexes is the best defined (Figure 1). We present here an adaptable glucocorticoid receptor (GR) immunoprecipitation assay and in vitro GR center dot hsp90 reconstitution method that may be readily used to probe eukaryotic hsp90 functional activity, hsp90-mediated steroid receptor ligand binding, and molecular chaperone cofactor requirements. For example, this assay can be used to test hsp90 cofactor requirements and the effects of adding exogenous compounds to the reconstitution process. The GR has been a particularly useful system for studying hsp90 because the receptor must be bound to hsp90 to have an open ligand binding cleft that is accessible to steroid(3). Endogenous, unliganded GR is present in the cytoplasm of mammalian cells noncovalently bound to hsp90. As found in the endogenous GR center dot hsp90 heterocomplex, the GR ligand binding cleft is open and capable of binding steroid. If hsp90 dissociates from the GR or if its function is inhibited, the receptor is unable to bind steroid and requires reconstitution of the GR center dot hsp90 heterocomplex before steroid binding activity is restored(4). GR can be immunoprecipitated from cell cytosol using a monoclonal antibody, and proteins such as hsp90 complexed to the GR can be assayed by western blot. Steroid binding activity of the immunoprecipitated GR can be determined by incubating the immunopellet with [H-3] steroid. Previous experiments have shown hsp90-mediated opening of the GR ligand binding cleft requires hsp70, a second molecular chaperone also essential for eukaryotic cell viability. Biochemical activity of hsp90 and hsp70 are catalyzed by co-chaperone proteins Hop, hsp40, and p23(5). A multiprotein chaperone machinery containing hsp90, hsp70, Hop, and hsp40 are endogenously present in eukaryotic cell cytoplasm, and reticulocyte lysate provides a chaperone-rich protein source(6). In the method presented, GR is immunoadsorbed from cell cytosol and stripped of the endogenous hsp90/hsp70 chaperone machinery using mild salt conditions. The salt-stripped GR is then incubated with reticulocyte lysate, ATP, and K+, which results in the reconstitution of the GR center dot hsp90 heterocomplex and reactivation of steroid binding activity(7). This method can be utilized to test the effects of various chaperone cofactors, novel proteins, and experimental hsp90 or GR inhibitors in order to determine their functional significance on hsp90-mediated steroid binding(8-11).
引用
收藏
页数:8
相关论文
共 50 条
  • [41] The Hsp90 ensemble: coordinated Hsp90–cochaperone complexes regulate diverse cellular processes
    Serena Schwenkert
    Thorsten Hugel
    Marc B Cox
    Nature Structural & Molecular Biology, 2014, 21 : 1017 - 1021
  • [42] Protein phosphatase 5 is a major component of glucocorticoid receptor hsp90 complexes that possesses an FK506-binding type domain
    Silverstein, AM
    Galigniana, MD
    Chen, MS
    Owens-Grillo, JK
    Chinkers, M
    Pratt, WB
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R673 - R673
  • [43] Mutational analysis of the hsp90 binding protein p23
    Sullivan, WP
    Toft, DO
    FASEB JOURNAL, 1997, 11 (09): : A1328 - A1328
  • [44] Characterization of the nucleotide binding properties of the 90 kDa heat shock protein (Hsp90)
    Soti, C
    Csermely, P
    JOURNAL OF BIOSCIENCES, 1998, 23 (04) : 347 - 352
  • [45] Characterization of the nucleotide binding properties of the 90 kDa heat shock protein (Hsp90)
    Csaba Sőti
    Péter Csermely
    Journal of Biosciences, 1998, 23 : 347 - 352
  • [46] Interaction of cepharanthine with immobilized heat shock protein 90α (Hsp90α) and screening of Hsp90α inhibitors
    Haginaka, Jun
    Kitabatake, Tomoko
    Hirose, Iyo
    Matsunaga, Hisami
    Moaddel, Ruin
    ANALYTICAL BIOCHEMISTRY, 2013, 434 (01) : 202 - 206
  • [47] DEFINITION OF A NOVEL LIGAND-BINDING DOMAIN OF A NUCLEAR BHLH RECEPTOR - COLOCALIZATION OF LIGAND AND HSP90 BINDING ACTIVITIES WITHIN THE REGULABLE INACTIVATION DOMAIN OF THE DIOXIN RECEPTOR
    WHITELAW, ML
    GOTTLICHER, M
    GUSTAFSSON, JA
    POELLINGER, L
    EMBO JOURNAL, 1993, 12 (11): : 4169 - 4179
  • [48] Volume of Hsp90 Protein-Ligand Binding Determined by Fluorescent Pressure Shift Assay, Densitometry, and NMR
    Toleikis, Zigmantas
    Sirotkin, Vladimir A.
    Skvramavicius, Gediminas
    Smirnoviene, Joana
    Roumestand, Christian
    Matulis, Daumantas
    Petrauskas, Vytautas
    JOURNAL OF PHYSICAL CHEMISTRY B, 2016, 120 (37): : 9903 - 9912
  • [49] Chaperone Activity and Dimerization Properties of Hsp90α and Hsp90β in Glucocorticoid Receptor Activation by the Multiprotein Hsp90/Hsp70-Dependent Chaperone Machinery
    Morishima, Yoshihiro
    Mehta, Ranjit K.
    Yoshimura, Miyako
    Lau, Miranda
    Southworth, Daniel R.
    Lawrence, Theodore S.
    Pratt, William B.
    Nyati, Mukesh K.
    Osawa, Yoichi
    MOLECULAR PHARMACOLOGY, 2018, 94 (03) : 984 - 991
  • [50] HSP40 binding is the first step in the HSP90 chaperoning pathway for the progesterone receptor
    Hernández, MP
    Chadli, A
    Toft, DO
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (14) : 11873 - 11881